Zepp Health(US:ZEPP) Prnewswireยท2024-05-10 21:00Core Viewpoint - Zepp Health Corporation is currently below compliance standards set by the New York Stock Exchange due to its American depositary shares trading below $1.00 for a consecutive 30 trading-day period [1][2]. Compliance Status - The company has a six-month "Cure Period" to regain compliance with the minimum share price requirement of $1.00 per ADS [2]. - Compliance can be achieved if the closing share price is at least $1.00 on the last trading day of any calendar month during the Cure Period, along with an average closing price of at least $1.00 over the preceding 30 trading days [2]. Company Actions - Zepp Health has communicated its intention to address the deficiency within the Cure Period and is exploring options, including a potential reverse share split, pending board and shareholder approval [3]. - The NYSE notice does not have an immediate impact on the listing of the company's ordinary shares, provided that other listing requirements are met [3]. Company Overview - Zepp Health Corporation is a leader in smart wearables and health technology, focusing on optimizing health, fitness, and wellness through its brands, including Amazfit, Zepp Clarity, and Zepp Aura [4]. - The company has shipped over 200 million units and operates in more than 90 countries and regions [4]. - Founded in 2013 as Huami Corp., the company rebranded to Zepp Health Corporation in February 2021 to emphasize its health focus [4].